Longitudinal Diffusion Tensor Imaging Shows Progressive Changes in White Matter in Huntington's Disease

Journal of Huntington's Disease

Volumn 4, Issue 4, 2015, Pages 333-346

  Gregory, Sarah ^a   Cole, James H ^b,c   Farmer, Ruth E ^d   Rees, Elin M ^b   Roos, Raymund A C ^e   Sprengelmeyer, Reiner ^f   Durr, Alexandra ^g   Landwehrmeyer, Bernhard ^f   Zhang, Hui ^a   Scahill, Rachael I ^b   Tabrizi, Sarah J ^b   Frost, Chris ^d   Hobbs, Nicola Z ^b,h  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c IMPERIAL COLLEGE LONDON   (United Kingdom)

^d LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^e LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^f UNIVERSITY OF ULM   (Germany)

^g INSERM   (France)

^h IXICO PLC   (United Kingdom)

Author keywords

diffusion tensor imaging; Huntington's disease; longitudinal; symptomatic

Indexed keywords

ADULT; AGED; ARTICLE; BRAIN REGION; CAPSULA INTERNA; CLINICAL ARTICLE; CONTROLLED STUDY; CORPUS CALLOSUM; CROSS-SECTIONAL STUDY; DIFFUSION TENSOR IMAGING; FEMALE; FRACTIONAL ANISOTROPY; HUMAN; HUNTINGTON CHOREA; MALE; NUCLEAR MAGNETIC RESONANCE SCANNER; PRIORITY JOURNAL; WHITE MATTER; BRAIN; CASE CONTROL STUDY; CLINICAL TRIAL; LONGITUDINAL STUDY; MIDDLE AGED; MULTICENTER STUDY; PATHOLOGY; PROCEDURES;

ADULT; AGED; BRAIN; CASE-CONTROL STUDIES; DIFFUSION TENSOR IMAGING; FEMALE; HUMANS; HUNTINGTON DISEASE; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; WHITE MATTER;

EID: 84961721976     PISSN: 18796397     EISSN: 18796400     Source Type: Journal    
DOI: 10.3233/JHD-150173     Document Type: Article

References (82)

1. The Huntington's Disease Collaborative Research Group. A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. The Huntington's Disease Collaborative Research Group. Cell. 1993; 72 (6): 971-83.
2. Rosas HD, Koroshetz WJ, Chen YI, Skeuse C, Vangel M, Cudkowicz ME, et al. Evidence for more widespread cerebral pathology in early HD: An MRI-based morphometric analysis. Neurology. 2003; 60 (10): 1615-20.
3. Tabrizi SJ, Langbehn DR, Leavitt BR, Roos RA, Durr A, Craufurd D, et al. Biological and clinical manifestations of Huntington's disease in the longitudinal TRACK-HD study: Cross-sectional analysis of baseline data. Lancet Neurol. 2009; 8 (9): 791-801.
4. Aylward EH, Codori AM, Rosenblatt A, Sherr M, Brandt J, Stine OC, et al. Rate of caudate atrophy in presymptomatic and symptomatic stages of Huntington's disease. Mov Disord. 2000; 15 (3): 552-60.
5. Georgiou-Karistianis N, Gray MA, Dominguez DJ, Dymowski AR, Bohanna I, Johnston LA, et al. Automated differentiation of pre-diagnosis Huntington's disease from healthy control individuals based on quadratic discriminant analysis of the basal ganglia: The IMAGE-HD study. Neurobiol Dis. 2013; 51: 82-92.
6. Georgiou-Karistianis N, Scahill R, Tabrizi SJ, Squitieri F, Aylward E. Structural MRI in Huntington's disease and recommendations for its potential use in clinical trials. Neurosci Biobehav Rev. 2013; 37 (3): 480-90.
7. Bohanna I, Georgiou-Karistianis N, Sritharan A, Asadi H, Johnston L, Churchyard A, et al. Diffusion Tensor Imaging in Huntington's disease reveals distinct patterns of white matter degeneration associated with motor and cognitive deficits. Brain Imaging Behav. 2011; 5 (3): 171-80.
8. Della Nave R, Ginestroni A, Tessa C, Giannelli M, Piacentini S, Filippi M, et al. Regional distribution and clinical correlates of white matter structural damage in Huntington disease: A tract-based spatial statistics study. Am J Neuroradiol. 2010; 31 (9): 1675-81.
9. Delmaire C, Dumas EM, Sharman MA, van den Bogaard SJ, Valabregue R, Jauffret C, et al. The structural correlates of functional deficits in early huntington's disease. Hum Brain Ma. 2013; 34 (9): 2141-53.
10. Douaud G, Behrens TE, Poupon C, Cointepas Y, Jbabdi S, Gaura V, et al. In vivo evidence for the selective subcortical degeneration in Huntington's disease. Neuroimage. 2009; 46 (4): 958-66.
11. Hobbs NZ, Cole JH, Farmer RE, Rees EM, Crawford HE, Malone IB, et al. Evaluation of multi-modal, multi-site neuroimaging measures in Huntington's disease: Baseline results from the PADDINGTON study. Neuroimage Clin. 2013; 2 (1): 204-11.
12. Klöppel S, Draganski B, Golding CV, Chu C, Nagy Z, Cook PA, et al. White matter connections reflect changes in voluntary-guided saccades in pre-symptomatic Huntington's disease. Brain. 2008; 131 (1): 196-204.
13. Magnotta VA, Kim J, Koscik T, Beglinger LJ, Espinso D, Langbehn D, et al. Diffusion Tensor Imaging in Preclinical Huntington's Disease. Brain Imaging Behav. 2009; 3 (1): 77-84.
14. Matsui JT, Vaidya JG, Johnson HJ, Magnotta VA, Long JD, Mills JA, et al. Diffusion weighted imaging of prefrontal cortex in prodromal huntington's disease. Hum Brain Ma. 2014; 35 (4): 1562-73.
15. Reading SAJ, Yassa MA, Bakker A, Dziorny AC, Gourley LM, Yallapragada V, et al. Regional white matter change in pre-symptomatic Huntington's disease: A diffusion tensor imaging study. Psychiatry Res. 2005; 140 (1): 55-62.
16. Rizk-Jackson A, Stoffers D, Sheldon S, Kuperman J, Dale A, Goldstein J, et al. Evaluating imaging biomarkers for neurodegeneration in pre-symptomatic Huntington's disease using machine learning techniques. Neuroimage. 2011; 56 (2): 788-96.
17. Stoffers D, Sheldon S, Kuperman JM, Goldstein J, Corey-Bloom J, Aron AR. Contrasting gray and white matter changes in preclinical Huntington disease: An MRI study. Neurology. 2010; 74 (15): 1208-16.
18. Di Paola M, Luders E, Cherubini A, Sanchez-Castaneda C, Thompson PM, Toga AW, et al. Multimodal MRI analysis of the corpus callosum reveals white matter differences in presymptomatic and early Huntington's disease. Cereb Cortex. 2012; 22 (12): 2858-66.
19. Di Paola M, Phillips OR, Sanchez-Castaneda C, Di Pardo A, Maglione V, Caltagirone C, et al. MRI measures of corpus callosum iron and myelin in early Huntington's disease. Hum Brain Ma. 2014; 35 (7): 3143-51.
20. Dumas EM, van den Bogaard SJ, Ruber ME, Reilman RR, Stout JC, Craufurd D, et al. Early changes in white matter pathways of the sensorimotor cortex in premanifest Huntington's disease. Hum Brain Ma. 2012; 33 (1): 203-12.
21. Mascalchi M, Lolli F, Della Nave R, Tessa C, Petralli R, Gavazzi C, et al. Huntington disease: Volumetric, diffusion-weighted, and magnetization transfer MR imaging of brain. Radiology. 2004; 232 (3): 867-73.
22. Muller HP, Glauche V, Novak MJ, Nguyen-Thanh T, Unrath A, Lahiri N, et al. Stability of white matter changes related to Huntington's disease in the presence of imaging noise: A DTI study. PLoS Curr. 2011; 3: RRN1232.
23. Novak MJU, Seunarine KK, Gibbard CR, Hobbs NZ, Scahill RI, Clark CA, et al. White matter integrity in premanifest and early Huntington's disease is related to caudate loss and disease progression. Cortex. 2014; 52 (1): 98-112.
24. Phillips O, Sanchez-Castaneda C, Elifani F, Maglione V, Di Pardo A, Caltagirone C, et al. Tractography of the corpus callosum in Huntington's disease. PLoS One. 2013; 8 (9): e73280.
25. Phillips O, Squitieri F, Sanchez-Castaneda C, Elifani F, Caltagirone C, Sabatini U, et al. Deep white matter in Huntington's disease. PloS One. 2014; 9 (10): e109676.
26. Poudel GR, Stout JC, Domínguez D JF, Salmon L, Churchyard A, Chua P, et al. White matter connectivity reflects clinical and cognitive status in Huntington's disease. Neurobiol Dis. 2014; 65: 180-7.
27. Rosas HD, Lee SY, Bender AC, Zaleta AK, Vangel M, Yu P, et al. Altered white matter microstructure in the corpus callosum in Huntington's disease: Implications for cortical "disconnection". Neuroimage. 2010; 49 (4): 2995-3004.
28. Rosas HD, Tuch DS, Hevelone ND, Zaleta AK, Vangel M, Hersch SM, et al. Diffusion tensor imaging in presymptomatic and early Huntington's disease: Selective white matter pathology and its relationship to clinical measures. Mov Disord. 2006; 21 (9): 1317-25.
29. Poudel GR, Stout JC, Dominguez DJ, Churchyard A, Chua P, Egan GF, et al. Longitudinal change in white matter microstructure in Huntington's disease: The IMAGE-HD study. Neurobiol Dis. 2015; 74: 406-12.
30. Odish OF, Leemans A, Reijntjes RH, van den Bogaard SJ, Dumas EM, Wolterbeek R, et al. Microstructural brain abnormalities in Huntington's disease: A two-year follow-uHum Brain Ma. 2015; 36 (6): 2061-74.
31. Aylward EH, Nopoulos PC, Ross CA, Langbehn DR, Pierson RK, Mills JA, et al. Longitudinal change in regional brain volumes in prodromal Huntington disease. J Neurol Neurosurg Psychiatry. 2011; 82 (4): 405-10.
32. Ciarmiello A, Cannella M, Lastoria S, Simonelli M, Frati L, Rubinsztein DC, et al. Brain white-matter volume loss and glucose hypometabolism precede the clinical symptoms of Huntington's disease. J Nucl Med. 2006; 47 (2): 215-22.
33. Hobbs NZ, Henley SM, Ridgway GR, Wild EJ, Barker RA, Scahill RI, et al. The progression of regional atrophy in premanifest and early Huntington's disease: A longitudinal voxel-based morphometry study. J Neurol Neurosurg Psychiatry. 2010; 81 (7): 756-63.
34. Rosas HD, Reuter M, Doros G, Lee SY, Triggs T, Malarick K, et al. A tale of two factors: What determines the rate of progression in Huntington's disease? A longitudinal MRI study. Mov Disord. 2011; 26 (9): 1691-7.
35. Squitieri F, Cannella M, Simonelli M, Sassone J, Martino T, Venditti E, et al. Distinct brain volume changes correlating with clinical stage, disease progression rate, mutation size, and age at onset prediction as early biomarkers of brain atrophy in Huntington's disease. CNS Neurosci Thera. 2009; 15 (1): 1-11.
36. Tabrizi SJ, Reilmann R, Roos RA, Durr A, Leavitt B, Owen G, et al. Potential endpoints for clinical trials in premanifest and early Huntington's disease in the TRACK-HD study: Analysis of 24 month observational data. Lancet Neurol. 2012; 11 (1): 42-53.
37. Tabrizi SJ, Scahill RI, Durr A, Roos RA, Leavitt BR, Jones R, et al. Biological and clinical changes in premanifest and early stage Huntington's disease in the TRACK-HD study: The 12-month longitudinal analysis. Lancet Neurol. 2011; 10 (1): 31-42.
38. Tabrizi SJ, Scahill RI, Owen G, Durr A, Leavitt BR, Roos RA, et al. Predictors of phenotypic progression and disease onset in premanifest and early-stage Huntington's disease in the TRACK-HD study: Analysis of 36-month observational data. Lancet Neurol. 2013; 12 (7): 637-49.
39. Hobbs NZ, Farmer RE, Rees EM, Cole JH, Haider S, Malone IB, et al. Short-interval observational data to inform clinical trial design in Huntington's disease. J Neurol Neurosurg Psychiatry. 2015; 86 (12): 1291-8.
40. Beaulieu C. The basis of anisotropic water diffusion in the nervous system-A technical review. NMR Biomed. 2002; 15 (7-8): 435-55.
41. Rees EM, Scahill RI, Hobbs NZ. Longitudinal neuroimaging biomarkers in Huntington's disease. J Huntingtons Dis. 2013; 2 (1): 21-39.
42. Domínguez DJF, Egan GF, Gray MA, Poudel GR, Churchyard A, Chua P, et al. Multi-modal neuroimaging in premanifest and early Huntington's disease: 18 month longitudinal data from the IMAGE-HD Study. PloS One. 2013; 8 (9): e74131.
43. Vandenberghe W, Demaerel P, Dom R, Maes F. Diffusion-weighted versus volumetric imaging of the striatum in early symptomatic Huntington's disease. J Neurol. 2009; 256 (1): 109-14.
44. Smith SM, Jenkinson M, Johansen-Berg H, Rueckert D, Nichols TE, Mackay CE, et al. Tract-based spatial statistics: Voxelwise analysis of multi-subject diffusion data. Neuroimage. 2006; 31 (4): 1487-505.
45. Weaver KE, Richards TL, Liang O, Laurino MY, Samii A, Aylward EH. Longitudinal diffusion tensor imaging in Huntington's Disease. Exp Neurol. 2009; 216 (2): 525-9.
46. Sritharan A, Egan GF, Johnston L, Horne M, Bradshaw JL, Bohanna I, et al. A longitudinal diffusion tensor imaging study in symptomatic Huntington's disease. J Neurol Neurosurg Psychiatry. 2010; 81 (3): 257-62.
47. Unified Huntington's Disease Rating Scale: Reliability and consistency. Huntington Study Group. Mov Disord. 1996; 11 (2): 136-42.
48. Odish OF, Caeyenberghs K, Hosseini H, van den Bogaard SJ, Roos RA, Leemans A. Dynamics of the connectome in Huntington's disease: A longitudinal diffusion MRI study. Neuroimage Clin. 2015; 9: 32-43.
49. Shoulson I, Fahn S. Huntington disease: Clinical care and evaluation. Neurology. 1979; 29 (1): 1-3.
50. Müller HP, Grön G, Sprengelmeyer R, Kassubek J, Ludolph AC, Hobbs N, et al. Evaluating multicenter DTI data in Huntington's disease on site specific effects: An ex post facto approach. Neuroimage Clin. 2013; 2 (1): 161-7.
51. Cook PA, Bai Y, Nedjati-Gilani S, Seunarine KK, Hall MG, Parker GJ, et al. editors. Camino: Open-Source Diffusion-MRI Reconstruction and Processing. 14th Scientific Meeting of the International Society for Magnetic Resonance in Medicine; 2006; Seattle, WA, USA.
52. Zhang H, Yushkevich PA, Alexander DC, Gee JC. Deformable registration of diffusion tensor MR images with explicit orientation optimization. Med Image Anal. 2006; 10 (5): 764-85.
53. Zhang H, Avants BB, Yushkevich PA, Woo JH, Wang S, McCluskey LF, et al. High-dimensional spatial normalization of diffusion tensor images improves the detection of white matter differences: An example study using amyotrophic lateral sclerosis. IEEE Trans Med Imaging. 2007; 26 (11): 1585-97.
54. Wang Y, Gupta A, Liu Z, Zhang H, Escolar ML, Gilmore JH, et al. DTI registration in atlas based fiber analysis of infantile Krabbe disease. Neuroimage. 2011; 55 (4): 1577-86.
55. Muller MJ, Mazanek M, Weibrich C, Dellani PR, Stoeter P, Fellgiebel A. Distribution characteristics, reproducibility, and precision of region of interest-based hippocampal diffusion tensor imaging measures. AJNR Am J Neuroradiol. 2006; 27 (2): 440-6.
56. Keihaninejad S, Zhang H, Ryan N, Malone I, Frost C, Cardoso M, et al. Longitudinal changes in fiber tract integrity in Alzheimer's disease: A serial diffusion tensor imaging study. Alzheimers Dement. 2012; 8 (S4): 30-1.
57. Lee CE, Danielian LE, Thomasson D, Baker EH. Normal regional fractional anisotropy and apparent diffusion coefficient of the brain measured on a 3 T MR scanner. Neuroradiology. 2009; 51 (1): 3-9.
58. Mori S, Oishi K, Jiang H, Jiang L, Li X, Akhter K, et al. Stereotaxic white matter atlas based on diffusion tensor imaging in an ICBM template. Neuroimage. 2008; 40 (2): 570-82.
59. Cole JH, Farmer RE, Rees EM, Johnson HJ, Frost C, Scahill RI, et al. Test-Retest Reliability of Diffusion Tensor Imaging in Huntington's Disease. PLoS Curr. 2014; 6: pii: ecurrents.hd.f19ef63fff962f5cd9c0e88f4844f43b.
60. Ourselin S, Roche A, Subsol G, Pennec X, Ayache N. Reconstructing a 3D structure from serial histological sections. Image Vis Comput. 2001; 19 (1-2): 25-31.
61. Modat M, Ridgway GR, Taylor ZA, Lehmann M, Barnes J, Hawkes DJ, et al. Fast free-form deformation using graphics processing units. Comput Methods Programs Biomed. 2010; 98 (3): 278-84.
62. Benjamini Y, Hochberg Y. Controlling the false discovery rate-a practical and powerful approach to multiple testing. J R Stat Soc Series B Stat Methodol. 1995; 57 (1): 289-300.
63. Crawford HE, Hobbs NZ, Keogh R, Langbehn DR, Frost C, Johnson H, et al. Corpus callosal atrophy in premanifest and early Huntington's disease. J Huntingtons Dis. 2013; 2 (4): 517-26.
64. Jones DK, Knosche TR, Turner R. White matter integrity, fiber count, and other fallacies: The do's and don'ts of diffusion MRI. Neuroimage. 2013; 73: 239-54.
65. Song SK, Sun SW, Ju WK, Lin SJ, Cross AH, Neufeld AH. Diffusion tensor imaging detects and differentiates axon and myelin degeneration in mouse optic nerve after retinal ischemia. Neuroimage. 2003; 20 (3): 1714-22.
66. Sun SW, Liang HF, Cross AH, Song SK. Evolving Wallerian degeneration after transient retinal ischemia in mice characterized by diffusion tensor imaging. Neuroimage. 2008; 40 (1): 1-10.
67. Van Camp N, Blockx I, Camón L, De Vera N, Verhoye M, Veraart J, et al. A complementary diffusion tensor imaging (DTI)-histological study in a model of Huntington's disease. Neurobiol Aging. 2012; 33 (5): 945-59.
68. Song SK, Yoshino J, Le TQ, Lin SJ, Sun SW, Cross AH, et al. Demyelination increases radial diffusivity in corpus callosum of mouse brain. Neuroimage. 2005; 26 (1): 132-40.
69. Budde MD, Xie M, Cross AH, Song SK. Axial diffusivity is the primary correlate of axonal injury in the experimental autoimmune encephalomyelitis spinal cord: A quantitative pixelwise analysis. J Neurosci. 2009; 29 (9): 2805-13.
70. Concha L, Gross DW, Wheatley BM, Beaulieu C. Diffusion tensor imaging of time-dependent axonal and myelin degradation after corpus callosotomy in epilepsy patients. Neuroimage. 2006; 32 (3): 1090-9.
71. Della Nave R, Ginestroni A, Diciotti S, Salvatore E, Soricelli A, Mascalchi M. Axial diffusivity is increased in the degenerating superior cerebellar peduncles of Friedreich's ataxia. Neuroradiology. 2011; 53 (5): 367-72.
72. Jensen JH, Helpern JA. MRI quantification of non-Gaussian water diffusion by kurtosis analysis. NMR Biomed. 2010; 23 (7): 698-710.
73. Zhang H, Schneider T, Wheeler-Kingshott CA, Alexander DC. NODDI: Practical in vivo neurite orientation dispersion and density imaging of the human brain. Neuroimage. 2012; 61 (4): 1000-16.
74. Zhang H, Hubbard PL, Parker GJM, Alexander DC. Axon diameter mapping in the presence of orientation dispersion with diffusion MRI. Neuroimage. 2011; 56 (3): 1301-15.
75. Assaf Y, Blumenfeld-Katzir T, Yovel Y, Basser PJ. AxCaliber: A method for measuring axon diameter distribution from diffusion MRI. Magn Reson Med. 2008; 59 (6): 1347-54.
76. Tournier JD, Mori S, Leemans A. Diffusion tensor imaging and beyond. Magn Reson Med. 2011; 65 (6): 1532-56.
77. Penney JB, Vonsattel JP, MacDonald ME, Gusella JF, Myers RH. CAG repeat number governs the development rate of pathology in huntington's disease. Ann Neurol. 1997; 41 (5): 689-92.
78. Papadakis NG, Xing D, Huang CL, Hall LD, Carpenter TA. A comparative study of acquisition schemes for diffusion tensor imaging using MRI. J Magn Reson. 1999; 137 (1): 67-82.
79. Jones DK. The effect of gradient sampling schemes on measures derived from diffusion tensor MRI: A Monte Carlo study. Magn Reson Med. 2004; 51 (4): 807-15.
80. Poonawalla AH, Zhou XJ. Analytical error propagation in diffusion anisotropy calculations. J Magn Reson Imaging. 2004; 19 (4): 489-98.
81. Barrio-Arranz G, de Luis-Garcia R, Tristan-Vega A, Martin-Fernandez M, Aja-Fernandez S. Impact of MR Acquisition Parameters on DTI Scalar Indexes: A Tractography Based Approach. PloS One. 2015; 10 (10): e0137905.
82. Muller HP, Sussmuth SD, Landwehrmeyer GB, Ludolph A, Tabrizi SJ, Kloppel S, et al. Stability effects on results of diffusion tensor imaging analysis by reduction of the number of gradient directions due to motion artifacts: An application to presymptomatic Huntington's disease. PLoS Curr. 2011; 3: RRN1292.